Chugai Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chugai Pharmaceutical Co Ltd with three other
companies in this sector in Japan:
Kyowa Hakko Kirin Company Limited
sales of 353.38 billion Japanese Yen [US$3.31 billion]
Mitsubishi Tanabe Pharma Corp
(423.98 billion Japanese Yen [US$3.98 billion]
of which 74%
was Domestic Ethical Drug), and
Eisai Company Limited
(539.10 billion Japanese Yen [US$5.06 billion]
of which 54%
was Pharmaceutical Business -Japan).
Chugai Pharmaceutical Co Ltd reported sales of ¥534.20 billion (US$5.01 billion)
December of 2017.
increase of 8.6%
versus 2016, when the company's sales were ¥491.78 billion.